Previous studies have demonstrated that CSF3 release in bone tissue disrupts the balance between bone formation and resorption, leading to pathological conditions associated with excessive bone resorption, such as periodontitis and osteoporosis [50]. Here, CSF3 is linked to osteoporosis.